NAGL MedTech

08/04/2022

NAGLREITER® MDDO is officially rebranding to NAGL MedTech™ in order to more accurately convey the broad range of services we offer to the MedTech community.

With a diverse offering of services ranging from Spec Development to Contract Manufacturing, to Company Incubation and more, NAGL MedTech™ more accurately encompasses the breadth of services we offer.

We pride ourselves on being a complete solution for all aspects of the MedTech industry, no matter what stage of the process you are in.

To learn more about rebranding, click here: https://nmddo.com/

06/23/2020

The Medical Device Contract Manufacturing Market is expected to exceed $97B by 2026. Partnering with Contract Manufacturing partners can be challenging. Big houses, you get ignored and lost in long term contracts, smaller engineering houses lack the capability:

The NAGLREITER™ value proposition is doing more than just building great products, we aim to equally build great companies. In order to become truly great, it’s essential to have validated production capabilities that meet the commercial demands as well as the acceptable cost targets. Early commercial data and an ability to manufacture product unlocks incredible company value. For many young MedTech startups it’s equally important that this manufacturing capability is highly transferable (no strings attached) either to a Strategic acquisition or perhaps a high-volume manufacturer. At NAGLREITER™, our manufacturing activity and controlled environments are flexible enough to be conducted either in the client’s own quality system or in the NAGLREITER™ QMS.

Visit our website to learn more https://hubs.ly/H0rPS8x0.

04/28/2020

We hope everyone remains healthy and safe during this COVID-19 crisis. NAGLREITER™ remains open, working on all programs with minimal delays in accordance with the recommended actions from the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO).

We are being proactive, utilizing our systems and technologies to ensure optimal project continuity and do not anticipate that you will experience any difference in our responsiveness or support. We are committed to working through these challenging circumstances and are here to support you in every way that we can. If you have any questions or concerns, please contact us at [email protected].

04/21/2020

NAGLREITER™ has extensive experience in designing and developing neuro catheter systems, as well as a full library of models. We have the ability to push the limits of trackability, pushability, torquability, and a wide range of clot models.

03/24/2020

As part of our service offerings, we have extended the usage of our telepresence Double Robotics equipment, a self-driving videoconferencing robot that allows clients to tour our facility, attend meetings, and feel more connected to the team, granting a physical presence from anywhere in the world!

03/12/2020

NAGLREITER™ is proud to announce a Tel Aviv based partnership with Iridium Consultancy & Technologies aimed to optimally bridge Israeli medical technologies seeking a deeper presence into the US market. Click below to read the full press release!

03/05/2020

NAGLREITER™ has extensive experience in designing and manufacturing self-expanding nitinol structures (braided, cut tube, etc).

Does your company have a nitinol device that needs developing? Click below to contact us today: https://hubs.ly/H0nk7YD0

03/03/2020

March 7th-9th, join us at the upcoming Surgical Disruptive Technology Summit in Houston, TX where we'll exhibit our services and discuss our president, Brett Naglreiter, will be on the Sunday VC Incubator panel. Make sure to stop by our booth for a chat! 👍 https://hubs.ly/H0nkhFv0

02/25/2020

NAGLREITER™ has extensive experience in specialized coverings. Below is an example of a device that takes advantage of our electrospinning technology for an embolic agent. Contact us today to know how this specialty can aid your product development.

02/20/2020

Have you checked out our latest press release? We recently came together with Vascular Disease Management to emphasize our mission and educate others on our model that accelerates the time to market for startups as well as large industry advanced R&D by combining a precise and thorough system.

January 29, 2020, Miramar, FL – NAGLREITER™ (www.nmddo.com) is a MedTech “Elevator / Incubator” aimed at Innovating MedTech innovation. The NAGLREITER™ model accelerates the time to market for startups as well as large industry advanced R&D by combining:

02/18/2020

Join us tomorrow at the Medical Device Israel (MDI) Expo in Tel Aviv where we'll be exhibiting at booth #26! Our VP of Sales, Tim Blair, will be presenting an emerging model for medical device success and how to win in today's environment. https://hubs.ly/H0n31DV0